课题基金 / 基金详情

Visualizing Immune Responses in vivo: a systems biology approach

Visualizing Immune Responses in vivo: a systems biology approach
体内免疫反应可视化:一种系统生物学方法
批准号:
7738611
负责人:
Dan Gabriel Duda
金额:
$22.55万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2011-06-30

项目摘要

项目成果

Dan Gabriel Duda的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):本研究的目标是建立一种结合纳米晶体免疫结构物和荧光多光子激光扫描显微镜来研究肿瘤中的免疫细胞的多重活体内细胞学技术。在肿瘤细胞免疫反应的研究中,原位肿瘤模型中细胞间相互作用、细胞表型和瘤内细胞分布的检测是剖析免疫治疗成败机制的关键。不幸的是,多种细胞类型与传统荧光团的时间和空间相互作用的观察受到其广泛光谱特性的限制。我们建议通过开发和优化在小鼠身上使用纳米晶体-抗体复合体的输注方案来解决这个问题,这应该允许我们通过多光子激光扫描显微镜同时区分五个或更多特定的探针(目标1)。目标是建立和利用有针对性的纳米晶体免疫构建物,用于在免疫治疗期间对肿瘤中的免疫细胞进行体内细胞学和功能分析(AIMS 2)。建立这种具有纳米晶体免疫结构的多路体内成像技术将为进一步了解与活肿瘤或其他疾病组织基质中的免疫反应相关的分子、细胞和生理事件创造独特的机会,可能转化为发现和验证新的治疗靶点。此外,这里使用的实验系统有可能加强对预后不佳的疾病--肝癌--的癌症研究。) 公共卫生相关性:目前使用传统荧光团观察多种免疫细胞类型与肿瘤的时间和空间相互作用的现有活体成像技术由于难以同时成像多种颜色而受到限制。我们建议通过开发和优化在小鼠身上使用新型纳米晶体-抗体复合体的输注方案来解决这个问题,这应该允许我们通过三维活体内多光子激光扫描显微镜同时区分五个或更多特定的探针。来自这笔赠款的信息可能会提高癌症免疫治疗方法的临床实用性。
英文摘要
DESCRIPTION (provided by applicant): The objective of this study is to establish a multiplexed intravital cytometry technique by combining nanocrystal-immunoconstructs and fluorescence multiphoton laser-scanning microscopy to study immune cells in tumors. In studies of the cellular immune response against tumors, the detection of cell-cell interactions, cell phenotype and intra-tumor cell distribution in orthotopic tumor models are critical to dissect the mechanisms of successful or failed immunotherapies. Unfortunately, observation of the temporal and spatial interactions of multiple cell types with traditional fluorophores is limited by their broad spectral characteristics. We propose to solve this problem by developing and optimizing infusion protocols in mice using nanocrystal-antibody complexes, which should allow us to distinguish simultaneously five or more specific probes by multiphoton laser-scanning microscopy (Aim 1). The goal is to establish and utilize targeted nanocrystal-immunoconstructs for in vivo cytometric and functional analyses of immune cells in tumors during immunotherapy (Aims 2). Establishing this multiplexed in vivo imaging technique with nanocrystal-immunoconstructs will create unique opportunities for further understanding the molecular, cellular and physiological events associated with immune responses in the stroma of living tumors or other diseased tissues, potentially translating into the discovery and validation of new therapeutic targets. In addition, the experimental system employed here has the potential to enhance cancer research in a disease - liver cancer - with dismal prognosis.) PUBLIC HEALTH RELEVANCE: Currently available intravital imaging techniques for observation of temporal and spatial interactions of multiple immune cell types with tumors using traditional fluorophores are limited by difficulties in concomitantly imaging multiple colors. We propose to solve this problem by developing and optimizing infusion protocols in mice using novel nanocrystal-antibody complexes, which should allow us to distinguish simultaneously five or more specific probes by three-dimensional intravital multiphoton laser-scanning microscopy. Information from this grant may elevate the clinical utility of immunotherapy approaches for cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining Optimal Radiotherapy Dose and Fractionation in Combination with Preoperative Immuno-Chemotherapy in Early-Stage Triple Negative Breast Cancer
  • 批准号:
    10512391
  • 项目类别:
  • 资助金额:
    $35.55万
  • 财政年份:
    2023
  • 负责人:
    Dan Gabriel Duda
  • 依托单位:
Vascularized tumor explants for drug testing
  • 批准号:
    10317398
  • 项目类别:
  • 资助金额:
    $37.81万
  • 财政年份:
    2021
  • 负责人:
    Dan Gabriel Duda
  • 依托单位:
Radiation and CSPG4-specifc CAR T cell based combinatorial therapy for the in vivo treatment of TNBC
  • 批准号:
    10290575
  • 项目类别:
  • 资助金额:
    $8.37万
  • 财政年份:
    2021
  • 负责人:
    Dan Gabriel Duda
  • 依托单位:
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy
  • 批准号:
    10372211
  • 项目类别:
  • 资助金额:
    $44.33万
  • 财政年份:
    2021
  • 负责人:
    Dan Gabriel Duda
  • 依托单位:
海外基金